Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients. (Q47788413)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 1998

Language	Label	Description	Also known as
English	Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients.	scientific article published in May 1998

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Tangier disease

1 reference

based on heuristic

inferred from title

author name string

von Eckardstein A

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Huang Y

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Kastelein JJ

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Geisel J

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Real JT

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Kuivenhoven JA

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Miccoli R

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Noseda G

8

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Assmann G

9

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

publication date

1 May 1998

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Atherosclerosis

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

138

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

25-34

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Pre-beta HDL: structure and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Regulation of the concentration of pre beta high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Generation of pre-beta 1-HDL and conversion into alpha-HDL. Evidence for disturbed HDL conversion in Tangier disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Biochemical characterization of pre-beta 1 high-density lipoprotein from human ovarian follicular fluid: evidence for the presence of a lipid core

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Genetically determined absence of HDL-cholesterol and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Two novel molecular defects in the LCAT gene are associated with fish eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Plasma lipid transfer activities in hyper-high-density lipoprotein cholesterolemic and healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

An investigation of the role of lecithin: cholesterol acyltransferase and triglyceride-rich lipoproteins in the metabolism of pre-beta high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Sodium oleate-facilitated reassembly of apolipoprotein A-I with phosphatidylcholine.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Familial HDL deficiency due to marked hypercatabolism of normal apoA-I

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900280-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(97)00280-3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/9678768

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47788413&oldid=1522390006"